Skip to Content

Martin J. Korbling

Present Title & Affiliation

Primary Appointment

Professor of Medicine & Internist, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 423
Houston, TX 77030
Room Number: FC5.3056
Email: mkorblin@mdanderson.org

Education & Training

Degree-Granting Education

1972 Heidelberg University Medical School, Heidelberg, Germany, Medical Doctor, MD

Postgraduate Training

1979-1980 Fellowship, Johns Hopkins University Medical School, Baltimore, MD
1975-1978 Fellowship, Ulm University, Ulm, Germany
1974 Internship, Munich University, Garmisch-Partenkirchen, Germany
1973 Internship (Medizinalassistent), Heidelberg University Hospital, Heidelberg, Germany

Selected Publications

Peer-Reviewed Original Research Articles
1. Körbling M, Freireich EJ. 25 years of peripheral blood stem cell transplantation. Blood. e-Pub 4/2011. PMID: 21460243.
2. Ciurea SO, Saliba R, Rondon G, Pesoa S, Cano P, Fernandez-Vina M, Qureshi S, Worth LL, McMannis J, Kebriaei P, Jones RB, Korbling M, Qazilbash M, Shpall EJ, Giralt S, de Lima M, Champlin RE, Gajewski J. Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplant 45(3):429-36, 3/2010. e-Pub 8/2009. PMID: 19668237.
3. Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, Wang X, Thall PF, Champlin RE, Fernandez-Vina M. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 88(8):1019-24, 10/2009. PMID: 19855248.
4. Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, De Lima M, Okoroji JG, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I, Popat U. Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. Am J Hematol 84(6):335-7, 6/2009. PMID: 19384931.
5. Popat U, Saliba R, Thandi R, Hosing C, Qazilbash M, Anderlini P, Shpall E, McMannis J, Körbling M, Alousi A, Andersson B, Nieto Y, Kebriaei P, Khouri I, de Lima M, Weber D, Thomas S, Wang M, Jones R, Champlin R, Giralt S. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant 15(6). e-Pub 4/2009. PMID: 19450756.
6. Tam CS, Bassett R, Ledesma C, Korbling M, Alousi A, Hosing C, Kebraei P, Harrell R, Rondon G, Giralt SA, Anderlini P, Popat U, Pro B, Samuels B, Hagemeister F, Medeiros LJ, Champlin RE, Khouri IF. Mature results of the MD Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma. Blood 113(18). e-Pub 1/2009. PMID: 19168784.

Grant & Contract Support

Title: Extracorporeal thermo-ablation of circulating cancer cells/stem cells using targeted nanoshells
Funding Source: NIH/SBIR
Role: Principal Co-Investigator
Duration: 2008 - 2010

Last updated: 9/16/2011